Yes, flucloxacillin is an appropriate first-line oral therapy for uncomplicated cellulitis of the chin in patients without penicillin allergy or significant liver disease.
Flucloxacillin is a suitable β-lactam antibiotic that provides adequate coverage against streptococci and methicillin-sensitive Staphylococcus aureus, the primary pathogens in typical cellulitis. 1
Rationale for Flucloxacillin Use
The 2014 IDSA guidelines explicitly recommend β-lactam antibiotics for typical cellulitis, listing penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin as suitable oral options 1. Flucloxacillin belongs to the same class as dicloxacillin (antistaphylococcal penicillins) and provides equivalent coverage.
Key Clinical Points:
- Target pathogens: Facial cellulitis (including chin) is typically caused by β-hemolytic streptococci or methicillin-sensitive S. aureus 1, 2
- MRSA coverage unnecessary: For uncomplicated, non-purulent cellulitis without penetrating trauma, purulent drainage, or concurrent MRSA infection elsewhere, MRSA coverage is not needed 1
- Monotherapy is sufficient: Recent evidence demonstrates that flucloxacillin monotherapy is as effective as combination therapy with phenoxymethylpenicillin 3, and adding clindamycin provides no additional benefit while doubling the risk of diarrhea 4
Treatment Duration
Treat for 5 days if clinical improvement occurs by day 5 1. This shorter course is as effective as 10-day regimens for uncomplicated cellulitis with documented clinical response.
Dosing
Standard dosing is flucloxacillin 500 mg to 1 g orally four times daily 3, 5, 6.
Important Caveats
When NOT to use flucloxacillin alone:
- Penetrating trauma (especially injection drug use)
- Purulent drainage present
- Evidence of MRSA infection elsewhere
- Severe systemic features (high fever, hypotension, confusion) - consider parenteral therapy initially 1
Contraindications to flucloxacillin:
- Penicillin allergy (true IgE-mediated)
- Significant liver disease - flucloxacillin carries hepatotoxicity risk, though this is primarily documented for fluconazole in the provided drug label 7
Alternative agents if flucloxacillin unavailable:
- Cephalexin (500 mg four times daily)
- Cefazolin (if parenteral needed) - may have better tolerability profile than flucloxacillin 8
- Clindamycin (if true penicillin allergy)
Monitoring
Patients should show improvement within 2-3 days. If inflammation worsens initially after starting therapy, this may represent pathogen lysis releasing inflammatory enzymes rather than treatment failure 1. However, if no improvement by day 2-3 or worsening beyond initial 24-48 hours, reassess for:
- Abscess formation requiring drainage
- Necrotizing infection
- Atypical pathogens
- Non-infectious mimickers (venous stasis dermatitis, contact dermatitis) 2
The absence of blood cultures or tissue cultures is appropriate for typical, uncomplicated cellulitis 1. Reserve cultures for patients with malignancy, severe systemic features, or unusual predisposing factors.